Tenpoint Therapeutics to Join Investor Conferences in April
31 Mar 2025 //
BUSINESSWIRE
Tenpoint Therapeutics Names Carol Kearney Chief Commercial Officer
11 Mar 2025 //
BUSINESSWIRE
Tenpoint reveals Phase 3 data for vision drug after Visus merger
10 Jan 2025 //
BUSSINESSWIRE
Tenpoint Reveals Positive Phase 3 Data For BRIMOCHOL™ PF
09 Jan 2025 //
BUSINESSWIRE
Tenpoint launches with $70M to restore vision with stem cell therapies
12 Jul 2023 //
ENDPTS